To manufacture biotech drugs faster and more efficiently so that everyone, everywhere, can get them 

Our philosophy

Taking a viral vector or RNA-based therapy from pre-clinical development to the first GMP batch for clinical trials can be a complex journey. One of the greatest hurdles is the limited access to both specialized process development expertise and GMP manufacturing facilities that can quickly and cost-effectively deliver the high-quality product needed for clinical studies and beyond.

Exothera stands as end-to-end CDMO partner, ready to help you navigate these challenges. We bring the expertise and flexibility to efficiently complete process development and manufacture the precise quantity of therapy required to move your clinical trials forward, secure additional funding, and accelerate your therapy’s journey to market.